Biacore, Bruker Pen Deal to Jointly Develop New Proteomics Platform | GenomeWeb

NEW YORK, Oct. 31 – Swedish proteomics company Biacore and mass spectrometer developer Bruker Daltonics said Wednesday they had agreed to combine their technologies in an effort to develop a new proteomics system. 

Under the terms of the deal, Uppsala-based Biacore will contribute its surface plasmon resonance technology and Bruker Daltonics of Billerica, Mass., will offer its mass spectrometry capabilities for a new platform to be known as SPR-MS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.